stars 1 stars 2 stars 3

At iuvantium, our mission is to harness the power of cross disciplinary collaboration, cutting-edge technology, and ethical principles to revolutionize the field of immunotherapy. We strive to create a world where everyone, regardless of their background or circumstances, has access to the best healthcare. By merging material science, engineering principles, machine learning, and immunobiology, we develop a scalable and cost-effective immune modulation platform. Our platform empowers immunotherapy developers to enhance the effectiveness of a vaccine/drug’s performance in real life settings (compared to efficacy measured in the laboratory) and accessibility of their formulations, leading to breakthrough treatments for cancer and infectious diseases. Additionally, we are dedicated to decoding the complexities of the immune system, and eventually leveraging our algorithm to run clinical trials in-silico to predict outcomes, minimize safety risks for patients and significantly reduce the costs in translational medicine for our partners. We envision a future where the power of human compassion and collaboration transcends boundaries, making transformative healthcare solutions available to all. We aspire to be at the forefront of innovation in the field of immune therapies, revolutionizing the way diseases are treated and prevented. By decoding the intricacies of the immune system and harnessing the potential of inorganic materials, we pioneer novel approaches that shape the development of next-generation vaccines, cellular therapies, and drugs. Our vision is to serve as the catalyst for positive change, partnering with pharmaceutical companies to realize a world free from the shackles of cancer and infectious diseases. Through our work, we envision a future where preventable suffering is eradicated, lives are saved, and individuals are empowered to reach their fullest potential. Together, we will build a world where healthcare knows no boundaries and the human spirit

Website https://iuvantium.com
Employees 6 (6 on RocketReach)
Founded 2023
Industry Biotechnology Research

iuvantium Ltd. Questions

Bjoern Schimmoeller is the co-founder and Chief Executive Officer of iuvantium Ltd..

6 people are employed at iuvantium Ltd..

Top iuvantium Ltd. Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users